Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses

[1]  S. Johnston,et al.  Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation. , 2013, The Journal of allergy and clinical immunology.

[2]  R. Severson,et al.  The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. , 2012, The Journal of allergy and clinical immunology.

[3]  J. Davies,et al.  Budesonide and Formoterol Reduce Early Innate Anti-Viral Immune Responses In Vitro , 2011, PloS one.

[4]  C. Jenkins,et al.  Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps , 2011, Respiratory research.

[5]  C. Jenkins,et al.  Effect of different asthma treatments on risk of cold-related exacerbations , 2011, European Respiratory Journal.

[6]  M. Bates,et al.  Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  J. Gern.  The ABCs of Rhinoviruses, Wheezing, and Asthma , 2010, Journal of Virology.

[8]  S. Keleş,et al.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma , 2010, Mucosal Immunology.

[9]  P. Howarth,et al.  The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. , 2009, Proceedings of the American Thoracic Society.

[10]  N. Papadopoulos,et al.  Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  W. Busse,et al.  Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. , 2009, The Journal of allergy and clinical immunology.

[12]  I. Adcock,et al.  Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future , 2009, European Journal of Clinical Pharmacology.

[13]  H. Boushey,et al.  In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. , 2009, The Journal of allergy and clinical immunology.

[14]  N. Lukacs,et al.  The role of chemokines in virus-associated asthma exacerbations , 2008, Current allergy and asthma reports.

[15]  S. Stepaniants,et al.  Selection of housekeeping genes for real-time PCR in atopic human bronchial epithelial cells , 2008, European Respiratory Journal.

[16]  L. Palmberg,et al.  Effect of Budesonide and Formoterol on Il-6 and Il-8 Release from Primary Bronchial Epithelial Cells , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[17]  P. Avila,et al.  TLR3- and Th2 Cytokine-Dependent Production of Thymic Stromal Lymphopoietin in Human Airway Epithelial Cells1 , 2007, The Journal of Immunology.

[18]  S. Johnston,et al.  IFN-γ–induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations , 2007, Journal of Allergy and Clinical Immunology.

[19]  O. Majdic,et al.  Modulation of the Immune System by Human Rhinoviruses , 2006, International Archives of Allergy and Immunology.

[20]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[21]  L. Petecchia,et al.  Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. , 2006, Pulmonary pharmacology & therapeutics.

[22]  S. Johnston,et al.  Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.

[23]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[24]  W. Busse,et al.  The role of rhinovirus in asthma exacerbations. , 2005, The Journal of allergy and clinical immunology.

[25]  D. Proud,et al.  Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[26]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[27]  W. Busse,et al.  Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. , 2005, American journal of respiratory and critical care medicine.

[28]  Wai-ming Lee,et al.  Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group , 2005, Virus Genes.

[29]  L. Serpero,et al.  Modulation of the constitutive or cytokine-induced bronchial epithelial cell functions in vitro by fluticasone propionate. , 2003, Immunology letters.

[30]  W. Busse,et al.  Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. , 2002, The Journal of infectious diseases.

[31]  R. Brattsand,et al.  Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. , 2001, The European respiratory journal.

[32]  J. V. van Krieken,et al.  Experimental rhinovirus 16 infection increases intercellular adhesion molecule‐1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  M. Schroth,et al.  Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.

[34]  F. Hayden,et al.  Oral prednisone therapy in experimental rhinovirus infections. , 1996, The Journal of allergy and clinical immunology.

[35]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[36]  B. Sherry,et al.  Evidence for at least two dominant neutralization antigens on human rhinovirus 14 , 1985, Journal of virology.